News
September 26, 2025
Kent Imaging’s SnapshotNIR receives CE mark
Kent Imaging Inc. received CE marking for its SnapshotNIR imaging device which uses near-infrared spectroscopy to measure oxygenated and deoxygenated hemoglobin in the microvasculature. The non-invasive point-of-care device provides real-time data to clinicians to help them make decisions which can change the trajectory of a wound, from chronic and non-healing, into a healing one, significantly improving the patient’s quality of life.
**Kent Imaging's SnapshotNIR Set to Revolutionize Wound Care in Europe After Receiving CE Mark**
CALGARY, ALBERTA – Kent Imaging Inc., a leading innovator in medical imaging, has announced that its revolutionary SnapshotNIR device has been granted CE marking. This crucial certification paves the way for the device to be marketed and sold across Europe, promising to transform the landscape of wound care and significantly improve patient outcomes.
The SnapshotNIR is a cutting-edge, non-invasive imaging tool that utilizes near-infrared (NIR) spectroscopy to provide clinicians with real-time data on tissue oxygenation. By measuring both oxygenated and deoxygenated hemoglobin levels within the microvasculature – the tiny blood vessels within tissue – the device offers a unique and detailed look at the health of the area surrounding a wound.
This real-time information is invaluable for clinicians facing the challenge of chronic and non-healing wounds. Traditional wound assessment methods often rely on visual inspection and subjective evaluations. The SnapshotNIR provides objective, quantitative data, allowing healthcare professionals to make more informed decisions about treatment strategies.
The device's point-of-care design allows for convenient use directly at the patient's bedside or in outpatient clinics. This accessibility means that clinicians can quickly assess a wound's condition and adjust treatment plans accordingly, potentially preventing complications and accelerating the healing process.
The ability to accurately assess tissue oxygenation is particularly critical in managing conditions such as diabetic ulcers, pressure sores, and surgical wounds. When oxygen supply to the tissue is compromised, it can severely hinder the healing process, leading to prolonged suffering, increased risk of infection, and even amputation in severe cases.
With the SnapshotNIR, clinicians can identify areas with poor oxygenation early on, allowing for targeted interventions such as optimizing blood flow, debridement, or the application of advanced wound care products. By shifting the trajectory of a wound from chronic and non-healing to a healing one, the SnapshotNIR has the potential to dramatically improve the quality of life for countless patients across Europe. The CE mark signifies that the device meets stringent European safety, health, and environmental protection requirements, ensuring its reliability and effectiveness for healthcare providers and their patients.
CALGARY, ALBERTA – Kent Imaging Inc., a leading innovator in medical imaging, has announced that its revolutionary SnapshotNIR device has been granted CE marking. This crucial certification paves the way for the device to be marketed and sold across Europe, promising to transform the landscape of wound care and significantly improve patient outcomes.
The SnapshotNIR is a cutting-edge, non-invasive imaging tool that utilizes near-infrared (NIR) spectroscopy to provide clinicians with real-time data on tissue oxygenation. By measuring both oxygenated and deoxygenated hemoglobin levels within the microvasculature – the tiny blood vessels within tissue – the device offers a unique and detailed look at the health of the area surrounding a wound.
This real-time information is invaluable for clinicians facing the challenge of chronic and non-healing wounds. Traditional wound assessment methods often rely on visual inspection and subjective evaluations. The SnapshotNIR provides objective, quantitative data, allowing healthcare professionals to make more informed decisions about treatment strategies.
The device's point-of-care design allows for convenient use directly at the patient's bedside or in outpatient clinics. This accessibility means that clinicians can quickly assess a wound's condition and adjust treatment plans accordingly, potentially preventing complications and accelerating the healing process.
The ability to accurately assess tissue oxygenation is particularly critical in managing conditions such as diabetic ulcers, pressure sores, and surgical wounds. When oxygen supply to the tissue is compromised, it can severely hinder the healing process, leading to prolonged suffering, increased risk of infection, and even amputation in severe cases.
With the SnapshotNIR, clinicians can identify areas with poor oxygenation early on, allowing for targeted interventions such as optimizing blood flow, debridement, or the application of advanced wound care products. By shifting the trajectory of a wound from chronic and non-healing to a healing one, the SnapshotNIR has the potential to dramatically improve the quality of life for countless patients across Europe. The CE mark signifies that the device meets stringent European safety, health, and environmental protection requirements, ensuring its reliability and effectiveness for healthcare providers and their patients.
Category:
Technology